REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Janssen-Cilag S.R.O. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Janssen-Cilag S.R.O. Profile Updated: November 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Janssen-Cilag S.R.O. is a company based in Czech Republic, with its head office in Prague. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on May 03, 2004. 100 - 199 (2024) employees currently work for Janssen-Cilag S.R.O.. In 2022, the company reported a net sales revenue increase of 12.8%. Its’ total assets recorded a growth of 33.05%. In 2022, Janssen-Cilag S.R.O.’s net profit margin decreased by 1.43%.

Headquarters
Walterovo namesti 329/1
Prague; The City of Prague; Postal Code: 15800

Contact Details: Purchase the Janssen-Cilag S.R.O. report to view the information.

Website: http://www.janssen.com

Basic Information
Total Employees:
Purchase the Janssen-Cilag S.R.O. report to view the information.
Outstanding Shares:
Purchase the Janssen-Cilag S.R.O. report to view the information.
Registered Capital:
Purchase the Janssen-Cilag S.R.O. report to view the information.
Incorporation Date:
May 03, 2004
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Actelion Pharmaceuticals Cz S.R.O.
100%
Company Performance
Financial values in the chart are available after Janssen-Cilag S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
12.8%▲
Total operating revenue
13%▲
Operating profit (EBIT)
-58.06%▼
EBITDA
-48.78%▼
Net Profit (Loss) for the Period
-68.31%▼
Total assets
33.05%▲
Total equity
5.11%▲
Operating Profit Margin (ROS)
-1.54%▼
Net Profit Margin
-1.43%▼
Return on Equity (ROE)
-11.26%▼
Quick Ratio
-0.17%▼
Cash Ratio
-0.01%▼

Similar companies

Zentiva, K.S.
 
Teva Czech Industries S.R.O.
Novartis S.R.O.
 
Hartmann - Rico A.S.
Teva Pharmaceuticals Cr, S.R.O.
 
Lohmann & Rauscher, S.R.O.
Bioveta, A.S.
 
Novavax Cz A.S.
Ferring-Leciva, A.S.
 
Walmark, A.S.
Synthon, S.R.O.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo